CADL
Candel Therapeutics Inc
NASDAQ · Biotechnology
$5.83
+0.54 (+10.21%)
Open$5.46
Previous Close$5.29
Day High$5.95
Day Low$5.38
52W High$43.60
52W Low$28.51
Volume—
Avg Volume723.5K
Market Cap320.06M
P/E Ratio32.65
EPS$1.09
SectorBiotechnology
Analyst Ratings
Strong Buy
14 analysts
Price Target
+716.3% upside
Current
$5.83
$5.83
Target
$47.59
$47.59
$33.44
$47.59 avg
$47.92
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 45.25M | 41.90M | 41.45M |
| Net Income | -4,564,062 | -5,052,559 | -4,078,464 |
| Profit Margin | -10.1% | -12.1% | -9.8% |
| EBITDA | -6,328,796 | -6,835,485 | -6,691,447 |
| Free Cash Flow | -4,822,512 | -5,572,664 | -3,889,078 |
| Rev Growth | -8.7% | -6.2% | +3.8% |
| Debt/Equity | 0.84 | 0.77 | 1.12 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |